Active Ingredient(s): Betaxolol
FDA Approved: * October 27, 1989
Pharm Company: * SANOFI AVENTIS US
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Kerlone Overview

Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma.[1] Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affinity for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pre...

Read more Kerlone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Kerlone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 0.5%
  • Solution/drops: 0.5%
  • Suspension: 0.25%
  • Tablet: 10mg, 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Kerlone: (2 results)

Sorted by National Drug Code
  • 0025-5101 Kerlone 10 mg Oral Tablet by Sanofi-aventis U.S. LLC
  • 0025-5201 Kerlone 20 mg (Betaxolol 17.88 mg) Oral Tablet by Sanofi-aventis U.S. LLC

Other drugs which contain Betaxolol or a similar ingredient: (4 results)